Anti-TPP1/ CLN2/ GIG1 functional antibody

Anti-TPP1/ CLN2/ GIG1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to TPP1/TPP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T56262-Ab-1/ GM-Tg-hg-T56262-Ab-2Anti-Human TPP1 monoclonal antibodyHuman
GM-Tg-rg-T56262-Ab-1/ GM-Tg-rg-T56262-Ab-2Anti-Rat TPP1 monoclonal antibodyRat
GM-Tg-mg-T56262-Ab-1/ GM-Tg-mg-T56262-Ab-2Anti-Mouse TPP1 monoclonal antibodyMouse
GM-Tg-cynog-T56262-Ab-1/ GM-Tg-cynog-T56262-Ab-2Anti-Cynomolgus/ Rhesus macaque TPP1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T56262-Ab-1/ GM-Tg-felg-T56262-Ab-2Anti-Feline TPP1 monoclonal antibodyFeline
GM-Tg-cang-T56262-Ab-1/ GM-Tg-cang-T56262-Ab-2Anti-Canine TPP1 monoclonal antibodyCanine
GM-Tg-bovg-T56262-Ab-1/ GM-Tg-bovg-T56262-Ab-2Anti-Bovine TPP1 monoclonal antibodyBovine
GM-Tg-equg-T56262-Ab-1/ GM-Tg-equg-T56262-Ab-2Anti-Equine TPP1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T56262-Ab-1/ GM-Tg-hg-T56262-Ab-2; GM-Tg-rg-T56262-Ab-1/ GM-Tg-rg-T56262-Ab-2;
GM-Tg-mg-T56262-Ab-1/ GM-Tg-mg-T56262-Ab-2; GM-Tg-cynog-T56262-Ab-1/ GM-Tg-cynog-T56262-Ab-2;
GM-Tg-felg-T56262-Ab-1/ GM-Tg-felg-T56262-Ab-2; GM-Tg-cang-T56262-Ab-1/ GM-Tg-cang-T56262-Ab-2;
GM-Tg-bovg-T56262-Ab-1/ GM-Tg-bovg-T56262-Ab-2; GM-Tg-equg-T56262-Ab-1/ GM-Tg-equg-T56262-Ab-2
Products NameAnti-TPP1 monoclonal antibody
Formatmab
Target NameTPP1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TPP1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T56262-Ag-1Recombinant multi-species TPP1/ CLN2/ GIG1 protein
    ORF Viral VectorpGMLP002827human TPP1 Lentivirus plasmid
    ORF Viral VectorvGMLP002827human TPP1 Lentivirus particle
    ORF Viral VectorpGMLPm002751mouse Tpp1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002751mouse Tpp1 Lentivirus particle


    Target information

    Target IDGM-T56262
    Target NameTPP1
    Gene ID1200,12751,83534,709838,485337,101093296,515575,100070095
    Gene Symbol and SynonymsCLN2,GIG1,LPIC,SCAR7,TPP-1,TPP-I,TPP1
    Uniprot AccessionO14773,Q9EQV6,Q9XSB8,Q0V8B6
    Uniprot Entry NameTPP1_HUMAN,TPP1_RAT,TPP1_CANLF,TPP1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000166340
    Target ClassificationN/A

    The target: TPP1, gene name: TPP1, also named as CLN2, GIG1, LPIC, SCAR7, TPP-1. This gene encodes a member of the sedolisin family of serine proteases. The protease functions in the lysosome to cleave N-terminal tripeptides from substrates, and has weaker endopeptidase activity. It is synthesized as a catalytically-inactive enzyme which is activated and auto-proteolyzed upon acidification. Mutations in this gene result in late-infantile neuronal ceroid lipofuscinosis, which is associated with the failure to degrade specific neuropeptides and a subunit of ATP synthase in the lysosome. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.